You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Chapter title |
Discovery and Development of Novel Drugs
|
|---|---|
| Chapter number | 3 |
| Book title |
Blue Biotechnology
|
| Published in |
Progress in molecular and subcellular biology, January 2017
|
| DOI | 10.1007/978-3-319-51284-6_3 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-951282-2, 978-3-31-951284-6
|
| Authors |
Vesna Erakovic Haber, Radan Spaventi |
| Abstract |
Drug discovery and development process is nowadays conducted in relatively standardised sequence of phases, starting with Discovery and being followed by Preclinical, Clinical and Non-Clinical Development. Discovery phase is divided in Hit Finding, Lead generation, Lead Optimisation and Candidate Identification Phase. Main drivers of the whole process are regulatory requirements and the aim to eliminate the unnecessary spending by early elimination of unlikely drug candidates. Marine products, once purified, isolated and produced in required quantities, follow the same route as any other synthetic drug. |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 20 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 4 | 20% |
| Student > Bachelor | 3 | 15% |
| Researcher | 2 | 10% |
| Student > Master | 2 | 10% |
| Lecturer | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 6 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 20% |
| Biochemistry, Genetics and Molecular Biology | 4 | 20% |
| Agricultural and Biological Sciences | 2 | 10% |
| Chemistry | 1 | 5% |
| Unknown | 9 | 45% |